Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: PORPHYRINS - THERAPEUTIC USE, . Treffer: 13

2016

Smretschnig, E; Hagen, S; Glittenberg, C; Ristl, R; Krebs, I; Binder, S; Ansari-Shahrezaei, S Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy.
Eye (Lond). 2016; 30(6):805-811 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Hagen, S; Ansari-Shahrezaei, S; Smretschnig, E; Glittenberg, C; Krebs, I; Steiner, I; Binder, S Effect of photodynamic therapy on short-wavelength fundus autofluorescence in eyes with acute central serous chorioretinopathy.
Retina. 2015; 35(2):223-230
Web of Science PubMed FullText FullText_MUG

 

2013

Hagen, S; Ansari-Shahrezaei, S; Smretschnig, E; Glittenberg, C; Krebs, I; Graf, A; Binder, S The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy.
Graefes Arch Clin Exp Ophthalmol. 2013; 251(4):1081-1089
Web of Science PubMed FullText FullText_MUG

 

Krebs, I; Vécsei Marlovits, V; Bodenstorfer, J; Glittenberg, C; Ansari Shahrezaei, S; Ristl, R; Binder, S Comparison of Ranibizumab monotherapy versus combination of Ranibizumab with photodynamic therapy with neovascular age-related macular degeneration.
Acta Ophthalmol. 2013; 91(3):e178-e183 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Seidel, G; Werner, C; Weger, M; Steinbrugger, I; Haas, A Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation.
Acta Ophthalmol. 2013; 91(6):e482-e485 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Smretschnig, E; Ansari-Shahrezaei, S; Hagen, S; Glittenberg, C; Krebs, I; Binder, S Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
Retina. 2013; 33(2):316-323
Web of Science PubMed FullText FullText_MUG

 

2012

Smretschnig, E; Ansari-Shahrezaei, S; Moussa, S; Glittenberg, C; Krebs, I; Binder, S Half-fluence photodynamic therapy in acute central serous chorioretinopathy.
Retina. 2012; 32(10):2014-2019
Web of Science PubMed FullText FullText_MUG

 

2011

Ansari-Shahrezaei, S; Binder, S; Stur, M The effect of laser unit on photodynamic therapy spot size.
Graefes Arch Clin Exp Ophthalmol. 2011; 249(1):11-14
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Ansari-Shahrezaei, S; Ergun, E; Chong, R; Tufail, A; Wedrich, A; Stur, M Magnification-corrected photodynamic therapy.
Graefes Arch Clin Exp Ophthalmol. 2007; 245(3):333-337
Web of Science PubMed FullText FullText_MUG

 

2006

Ansari-Shahrezaei, S; Ergun, E; Stur, M The effect of axial length on photodynamic therapy.
Am J Ophthalmol. 2006; 141(4):699-702
Web of Science PubMed FullText FullText_MUG

 

Ansari-Shahrezaei, S; Ergun, E; Stur, M The effect of digital measurement software on photodynamic therapy.
Graefes Arch Clin Exp Ophthalmol. 2006; 244(2):137-142
Web of Science PubMed FullText FullText_MUG

 

Ergun, E; Maár, N; Ansari-Shahrezaei, S; Wimpissinger, B; Krepler, K; Wedrich, A; Stur, M Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
Am J Ophthalmol. 2006; 142(1):10-16
Web of Science PubMed FullText FullText_MUG

 

2001

Stur, M; Ansari-Shahrezaei, S The effect of axial length on laser spot size and laser irradiance.
Arch Ophthalmol. 2001; 119(9):1323-1328
Web of Science PubMed

 

© Meduni Graz Impressum